Ambev (NYSE:ABEV) Stock Price Target Lowered at Barclays

Key Points

• Barclays lowered Ambev’s price target from $3.50 to $3.00 while maintaining an “equal weight” rating. The new target implies approximately 13.16% upside from the previous close.
• Analyst sentiment remains cautious: Ambev has a consensus “Reduce” rating and an average price target of $3.01, with four Hold ratings and two Sell ratings.
• Ambev reported quarterly EPS of $0.05, in line with estimates, but revenue of $4.17 billion missed the $4.21 billion consensus. Shares fell 0.7% to $2.65, below their 50- and 200-day moving averages near $3.02.

Ambev (NYSE:ABEV - Get Free Report) had its target price decreased by investment analysts at Barclays from $3.50 to $3.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's price target suggests a potential upside of 13.16% from the stock's previous close.

A number of other brokerages have also commented on ABEV. UBS Group set a $2.85 price target on Ambev in a report on Tuesday, August 11th. Bank of America cut Ambev from a "neutral" rating to an "underperform" rating and set a $3.30 price objective for the company. in a report on Wednesday, October 7th. Scotiabank cut Ambev from a "sector outperform" rating to a "sector perform" rating in a report on Wednesday, July 15th. Wall Street Zen upgraded shares of Ambev from a "hold" rating to a "buy" rating in a report on Saturday, October 10th. Finally, Weiss Ratings downgraded Ambev from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday. Four research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Reduce" and an average price target of $3.01.

Ambev Stock Down 0.7%

Shares of Ambev stock traded down $0.02 during midday trading on Friday, reaching $2.65. 1,702,479 shares of the company's stock traded hands, compared to its average volume of 26,410,248. Ambev has a 52 week low of $2.28 and a 52 week high of $3.45. The company's 50 day simple moving average is $3.03 and its 200 day simple moving average is $3.02. The company has a market cap of $41.78 billion, a price-to-earnings ratio of 13.22, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.76 and a current ratio of 1.02.

Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The company reported $0.05 EPS for the quarter, meeting analysts' consensus estimates of $0.05. Ambev had a return on equity of 17.48% and a net margin of 18.47%. The business had revenue of $4.17 billion for the quarter, compared to analyst estimates of $4.21 billion. Equities analysts expect that Ambev will post 0.21 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Carla Smith De Vasconcellos Crippa Prado sold 60,757 shares of the business's stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $3.09, for a total value of $187,739.13. Following the completion of the sale, the insider directly owned 80,707 shares in the company, valued at approximately $249,384.63. The trade was a 42.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Institutional Investors Weigh In On Ambev

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. ARGA Investment Management LP increased its position in Ambev by 5.3% during the 3rd quarter. ARGA Investment Management LP now owns 1,299,756 shares of the company's stock valued at $3,795,000 after purchasing an additional 65,648 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its position in Ambev by 29.9% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 477,339 shares of the company's stock valued at $1,394,000 after buying an additional 109,796 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Ambev in the 3rd quarter worth $220,000. Vise Technologies Inc. raised its stake in shares of Ambev by 155.5% in the third quarter. Vise Technologies Inc. now owns 153,858 shares of the company's stock worth $449,000 after purchasing an additional 93,636 shares during the last quarter. Finally, VestGen Advisors LLC boosted its holdings in Ambev by 29.2% during the 3rd quarter. VestGen Advisors LLC now owns 16,267 shares of the company's stock worth $48,000 after acquiring an additional 3,679 shares during the last quarter. 8.13% of the stock is currently owned by institutional investors.

Key Headlines Impacting Ambev

Here are the key news stories impacting Ambev this week:

• Positive Sentiment: Ambev’s board approved a two-year program to repurchase up to 190 million shares. The company also completed its previous buyback and canceled 279 million repurchased shares, which could support earnings per share and shareholder returns. Ambev reports third-quarter results and approves share buyback program
• Positive Sentiment: Third-quarter revenue increased year over year, with management characterizing the company as delivering consistent growth despite challenging market conditions. Ambev delivers consistent growth in challenging markets
• Neutral Sentiment: Ambev reported adjusted earnings of $0.05 per share, matching the consensus estimate. Management discussed the quarterly performance and operating conditions during the earnings call. Ambev Q3 2026 earnings call transcript
• Negative Sentiment: Revenue of approximately $4.17 billion fell short of the roughly $4.21 billion analyst consensus, limiting the market’s reaction to the reported top-line growth. Ambev fiscal third-quarter earnings
• Negative Sentiment: Ambev’s third-quarter profit declined about 10% year over year. The earnings deterioration, together with the revenue miss, appears to be the main reason the stock has decreased despite the buyback announcement. Ambev profit falls in third quarter

Ambev Company Profile

Ambev SA is a Brazilian beverage company headquartered in São Paulo and one of the largest beverage producers in Latin America. Its principal business is the production, distribution and sale of beer, although it also offers soft drinks, carbonated beverages, bottled water, energy drinks and other non-alcoholic products.

The company's beer portfolio includes brands such as Brahma, Skol, Antarctica, Bohemia, Original, Budweiser, Stella Artois and Corona, with brand availability varying by market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.